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The angiotensin II type 1A receptor (AT1AR) plays an impor-
tant role in cardiovascular function and as such represents a
primary target for therapeutic intervention. The AT1AR is cou-
pled via Gq to the activation of phospholipase C, the hydrolysis
of phosphoinositides, release of calcium from intracellular
stores, and the activation of protein kinase C (PKC). We show
here that PKCI andPKCII exhibit differentmembrane trans-
location patterns in response to AT1AR agonist activation.
Whereas PKCII translocation to the membrane is transient,
PKCI displays additional translocation responses: persistent
membrane localization and oscillations between the membrane
and cytosol following agonist removal. The initial translocation
of PKCI requires the release of calcium from intracellular
stores and the activation of phospholipase C, but persistent
membrane localization is dependent upon extracellular calcium
influx. The mutation of any of the three PKC phosphorylation
consensus sites (Ser-331, Ser-338, and Ser-348) localized within
theAT1ARC-tail significantly increases the probability that per-
sistent increases in diacylglycerol levels and PKCI transloca-
tion responses will be observed. The persistent increase in
AT1AR-mediated diacylglycerol formation is mediated by the
activation of phospholipase D. Although the persistent PKCI
membrane translocation response is absolutely dependent upon
the PKC activity-dependent recruitment of an extracellular cal-
ciumcurrent, it does not require the activation of phospholipase
D. Taken together, we show that the patterning of AT1AR sec-
ond messenger response patterns is regulated by heterologous
desensitization and PKC isoform substrate specificity.
The angiotensin II type 1A receptor (AT1AR)5 is amember of
the large superfamily of G protein-coupled receptors. AT1ARs
are coupled via Gq to the stimulation of phospholipase C (PLC),
leading to increases in intracellular diacylglycerol (DAG), ino-
sitol 1, 4, 5, trisphosphate formation, and the release of calcium
from intracellular stores. Calcium and DAG stimulate the sub-
sequent activation of protein kinase C (1). AT1ARs have been
shown tomediatemost of the physiological actions of angioten-
sin II (Ang II), and this receptor subtype plays a principal role in
the control of Ang II-induced vascular functions, including cell
growth, vascular contraction, and inflammatory responses as
well as salt and water retention (2).
In addition to receptor-G protein coupling, agonist binding
toAT1ARs initiates a series of regulatory processes that contrib-
ute to receptor desensitization. AT1AR desensitization is an
adaptive processwhereby the cellular response to receptor acti-
vation diminishes following prolonged agonist exposure (3, 4).
There are several mechanisms by which AT1AR desensitization
is achieved, but phosphorylation of theAT1AR is themost rapid
means by which this receptor is desensitized. AT1AR desensiti-
zation is mediated by translocation of both protein kinase C
(PKC) and G protein-coupled receptor kinases to the activated
receptor, which mediates phosphorylation of serine and threo-
nine residues localized to the carboxyl-terminal tail of the
receptor (3–8). The rat AT1AR C-tail contains three consensus
sites for PKC phosphorylation. Mutational analysis indicates
that endogenous PKC will phosphorylate the AT1AR carboxyl-
terminal tail at either Ser-331, Ser-338, or Ser-348 in response
to either Ang II or phorbol ester treatment (9).
The release of calcium from intracellular stores in response
to G protein-coupled receptor stimulation represents a funda-
mental mechanism of cell signaling. The patterning of the cal-
cium signal and the activation of calcium-regulated effector
enzymes is critically important for the phosphorylation of cyto-
plasmic targets and the activation of different transcription fac-
tors leading to differential gene transcription in developing
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systems (10, 11). Calcium signaling via G protein-coupled
receptors is complex, involves multiple pathways, and leads to
transient, oscillatory, and persistent PKC activation patterns
(12–17). Moreover, similar PKC isozymes, such as PKCI and
PKCII, exhibit different response patterns to metabotropic
glutamate receptor 1a (mGluR1a)-stimulated second messen-
ger responses even when expressed in the same cell (17).
Angiotensin II-stimulated calcium signaling is typically char-
acterized by a biphasic response that is comprised of a rapid
release of calcium from intracellular stores followed by a slower
influx of extracellular calcium (1). The mechanism(s) by which
this biphasic response pattern is elicited is unclear, but DAG
formation also exhibits biphasic and sustained responses that
are essential for the regulation of vascular smooth muscle
function.
In the present study, we explored the possibility that differ-
ences in the activation patterns for PKCI and PKCII might
be associated with the biphasic and sustained second messen-
ger responses observed in response to AT1AR activation. We
found that mutation of any of the three consensus sites for
PKC-mediated phosphorylation in the AT1AR carboxyl-termi-
nal tail results in an increase in the probability that the activa-
tion of the AT1AR will result in the recruitment of an extracel-
lular calcium influx, persistent DAG formation in response to
phospholipase D (PLD) activation, and the persistent localiza-
tion of PKCI to the plasma membrane. The extracellular cal-
cium influx, but not DAG formation, is essential for sustained
PKCI membrane localization. Thus, the ability of the AT1AR
to escape heterologous desensitization in PKCI-expressing
cells allows the receptor to recruit additional secondmessenger
responses leading to sustained alterations in activity.
EXPERIMENTAL PROCEDURES
Materials—Human embryonic kidney cells (HEK 293) were
from American Tissue Culture Collection (Manassas, VA).
Fetal bovine serum, gentamicin, minimal essential medium,
and 0.05% trypsin containing 0.5 mM EDTA were purchased
from Invitrogen. BAPTA-AM was from Invitrogen Molecular
Probes (Burlington, ON). All other biochemical reagents were
purchased from Sigma, Fisher Scientific (Ottawa, ON), and
VWR (Mississauga, ON).
Cell Culture and Transfection—HEK 293 cells were main-
tained in minimal essential medium supplemented with 10%
(v/v) fetal bovine serum and 50 g/ml gentamicin at 37 °C in a
humidified atmosphere containing 5% CO2. The cells used in
each experiment were transiently transfected using a modified
calcium phosphate method (18). Cells were transfected with 5
g of receptor (AT1AR or AT1AR PKC phosphorylation site
mutants), 2 g of either EGFP-PKCI, EGFP-PKCII, or
EGFP-PKC, and 3g of the fluorescent DAG indicator EYFP-
PKC C1 (19) unless otherwise indicated in the figure legends.
Following an 18-h incubation period with the calcium phos-
phate transfection reagent at 37 °C, the cells were washed with
Hanks’ balanced salt solution (1.2mMKH2PO4, 5mMNaHCO3,
20 mM HEPES, 11 mM glucose, 116 mM NaCl, 4.7 mM KCl, 1.2
mM MgSO4, 2.5 mM CaCl2, pH 7.4) and then fed with 10 ml of
supplemented minimal essential medium (see above). Five
hours later, cells were plated on 15-mm collagen-coated glass
coverslips designed for use in a perfusion system (Warner
Instrument Corp.) or on collagen-coated 35-mm glass-bot-
tomed culture dishes (MatTek) for confocal live cell imaging
studies.
Synthesis of PLD1/2 siRNAs and Transfections—siRNA
duplexes corresponding to thehumanPLD1 (AAGTTAAGAGG-
AAATTCAAGC) and PLD2 cDNA (GACACAAAGTCTTGAT-
GAG) sequences were purchased from Dharmacon Research
(Lafayette, CO), and siCONTROLTM Non-Targeting siRNA 1
was utilized as a control. A full characterization of these
siRNA sequences for the knock down of PLD1 and PLD2
protein expression were published previously (20, 21). 100
pM siRNA duplex was transiently co-transfected into HEK
293 cells with cDNA constructs described in the figure leg-
ends using Lipofectamine 2000. Cells were utilized 48 h fol-
lowing transfection, and PLD protein knock down was con-
firmed by immunoblot.
Confocal Microscopy—Confocal microscopy was performed
on a Zeiss LSM-510 META laser scanning microscope using
Zeiss 63  1.4 numerical aperture oil immersion lens. EGFP
and YFP fluorescence was visualized with excitation at 488 nm
and 515–540-nm emission filter set. Fluorescent signals were
collected sequentially every 6.3 s using the Zeiss LSM software
time scan function. The cellular distribution and intracellular
trafficking of each of the EGFP-conjugated PKCs in cells co-
expressing FLAG-AT1AR or HA-AT1AR phosphorylation site
mutants were observed in transiently transfectedHEK 293 cells
plated on glass coverslips. Coverslips were attached to an
RC-25F perfusion chamber (Warner Instruments Corp.) with
vacuum grease, and the chamber was mounted onto a PH4
platform (Warner Instruments). Coverslips were perfused with
solutions from perfusion channels (Model VC-6 apparatus;
Warner Instruments) connected via tubing with the perfusion
chamber. The perfusing solutions were maintained at 37 °C
with the TC-344B Dual Channel Heater Controller (Warner
Instruments). The rate at which the perfusing solutions flow
through the perfusion chamber is 67l/s, and it takes30 s for
the perfusion chamber to fill with solution. Cells were initially
perfused with Hanks’ balanced salt solution for 500 s to estab-
lish base-line PKC distribution and to test for agonist-indepen-
dent responses. Next, 100 nM Ang II in Hanks’ balanced salt
solution was applied for 500 s or the times indicated in the
figures, and PKC responses were examined and classified as
transient (translocates only once from cytosol to plasma mem-
brane and then back to cytosol in the presence of agonist),
persistent (translocates to plasma membrane and remains
localized to membrane throughout agonist stimulation), or
repetitive (repeated translocation between cytosol and plasma
membrane; clear reappearance of PKC at the plasma mem-
brane and loss of cytosolic PKC). Lastly, Hanks’ balanced salt
solution was again applied for 500 s to wash off agonist. YFP-
PKC C1 is a DAG indicator that translocates from the cytosol
to the plasmamembrane in response to increases inmembrane
DAG concentration (17, 19). The cellular distribution and
intracellular trafficking of YFP-PKC C1 in HEK 293 cells co-
expressing FLAG-AT1AR or HA-AT1AR S331/338/348A were
visualized as described above.
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Electrophysiology—Patch clamp recordings on isolated
transfected cells were conducedwith anAxopatch 200 B ampli-
fier connected to a personal computer via aDigidate 1320 inter-
face. pCLAMP 9 software was used for data acquisition. Boro-
silicate patch pipettes were pulled with a Sutter microelectrode
puller and had typical resistances of 2–4Mwhen filledwith an
internal recording solution containing 118 mM Cesium meth-
anesulfonate, 4mMMgCl2, 0.5mMEGTA, 9mMHEPES, pH7.4.
The bath solution contained 116 mM NaCl, 2.5 mM CaCl2, 1.2
mM MgCl2, 11 mM glucose, 10 mM HEPES, pH 7.4. Ang II was
applied via a gravity-driven microperfusion system.
Currents were elicited by voltage ramps from 60 to 40
mV from a holding potential of20 mV. Whole cell conduct-
ance was determined from a regression to the current-voltage
data at negative voltages (30 to 60 mV), and in each case,
Ang II effects were leak subtracted by subtracting thewhole cell
conductance determined immediately before Ang II applica-
tion from that obtained in the presence of Ang II. Data were
analyzed in Clampfit and plotted in Sigmaplot. Statistical anal-
ysis was conducted in Sigmastat, with statistical significance set
at the 0.05 level.
Data Analysis—PKC translocation and DAG responses were
recorded as time series of 250–500 confocal images for each
experiment. Image analysis was performed using the Zeiss
LSM-510 physiology analysis software. The relative change in
cytoplasmic fluorescence intensity over timewas examined in a
5-m-diameter region of interest. Data were then normalized
between 0 and 1 to show the relative membrane localization of
PKC. 0 indicated PKC predominantly in the cytosol, and 1 indi-
cated loss of cytoplasmic PKC, which was taken to indicate that
PKC translocated to the plasma membrane. The relative mem-
brane localization was calculated using mean region of interest
values obtained for each fluorescent signal collected sequen-
tially during every 6.3-s scan, according to the equation (max
x)/(max-min), where max is the maximum mean region of
interest for a given time series,min is the minimum value, and
x is the value at a given 6.3-s scan.
All time course data were plotted
usingGraphPadPrism software. For
each experiment, the number of
cells in which the pertinent PKC
construct showed transient, persis-
tent, and repetitive responses were
counted and expressed as a propor-
tion of total number of responding
cells. Data were analyzed for statis-
tical significance with chi-square
tests using Excel. Because multiple
comparisons were made between
control and treatment groups, 
values were adjusted with the Bon-
ferroni correction factor (0.05/
number of comparison groups).
Error bars in the figures indicate
two standard deviations (95% con-
fidence intervals). Standard devia-
tions (S.D.), were calculated
according to the following equa-
tion: S.D.  sqrt(p(1  p)/n)*100 where p is the proportion
of cells showing a transient or persistent or repetitive
response for a given PKC construct and n is the total number
of responding cells expressing the given construct.
RESULTS
PKC Splice Variant-specific Plasma Membrane Transloca-
tion Responses—Because we previously observed differences in
EGFP-PKCI and EGFP-PKCII plasma membrane transloca-
tion responses to mGluR1a activation (17), we tested whether
differences in EGFP-PKCI and EGFP-PKCII plasma mem-
brane translocation responses might be observed following
AT1AR activationwith 100 nMAng II. InHEK 293 cells express-
ing both HA-AT1AR and EGFP-PKCII, EGFP-PKCII trans-
location to the plasma membrane was observed in 95% of
EGFP-PKCII-transfected cells (Fig. 1). In all responding cells a
transient translocation response was the only response pattern
observed for this PKC variant. In contrast, HA-AT1AR activa-
tion stimulated three different EGFP-PKCI translocation
response patterns: transient (87% of transfected cells), persis-
tent (9% of transfected cells), and repetitive (4% of transfected
cells) (Fig. 2A). In cells exhibiting persistent EGFP-PKCI
membrane localization to the plasmamembrane, EGFP-PKCI
remained localized to the plasma membrane even after agonist
wash out (Fig. 2B). In cells exhibiting repetitive EGFP-PKCI
translocation patterns, agonist treatment first resulted in the
transient translocation of EGFP-PKCI to the plasma mem-
brane, which upon the removal of agonist by perfusion was
replaced by EGFP-PKCI oscillations (Fig. 2C). To ensure that
PKC membrane translocation was AT1AR dependent, control
experiments were conducted with cells transfected solely with
EGFP-PKCI or EGFP-PKCII. No membrane translocation
was observed for either isoform in the absence of the AT1AR
transfection (data not shown). Taken together these observa-
tions suggested that PKCI and PKCII exhibit different pat-
terns of activation in response to AT1AR activation.
FIGURE 1. PKCII translocation response to AT1AR activation. HEK 293 cells were transfected with cDNA
plasmids encoding EGFP-PKCII (2 g) and HA-AT1AR (10 g) and treated with 100 nM Ang II. Shown are
representative images selected from a time series of 200–400 laser scanning confocal microscopic images
collected at 6.8–12.5-s intervals. The images demonstrate the transient translocation of GFP-PKCII in 47/47
cells tested. The data are plotted below as the relative change in EGFP fluorescence intensity in the circular
(white) region of interest with maximal cytosolic fluorescence normalized to zero and minimum cytoplasmic
fluorescence normalized to one. The data are collected from six independent experiments. The white bar
represents 10 m. The black bar represents the time of agonist treatment.
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PKCI-dependent Alterations in AT1AR-stimulated DAG
Formation—Previously, we observed that the co-expression of
PKCI, but not PKCII, with mGluR1a led to persistent
increases in intracellular DAG levels in response to receptor
activation (15). Therefore, we examined whether PKCI
expression alteredDAG responses inHEK 293 cells transfected
with HA-AT1AR utilizing a YFP-PKC C1 domain construct
that translocates from the cytosol to the plasma membrane in
response to increases in intracellular DAG concentrations (19).
We found that in cells expressing the AT1AR alone, agonist-
stimulated DAG responses were predominantly transient (72%
of cells) versus persistent (28%) and
in cells expressing both PKCII and
the AT1AR a similar result was
obtained (Fig. 3). However, in cells
expressing PKCI, AT1AR-stimu-
lated DAG responses were predom-
inantly persistent (60% of cells) (Fig.
3). Taken together, our data sug-
gested that DAG signaling in
response to AT1AR was altered by
the expression of PKCI.
Role of AT1AR Phosphorylation in
PKC Splice Variant-specific Trans-
location Responses—Because PKCI
expression altered AT1AR-stimu-
lated DAG formation from a pre-
dominantly transient to persistent
response pattern, we tested whether
PKC isoform-specific phosphoryla-
tion at three PKC consensus sites
(Ser-331, Ser-338, and Ser-348) (9)
in the AT1AR C-tail might contrib-
ute to differences in PKCI and
PKCII translocation patterns and
DAG responses. Themutation of all
three C-tail AT1AR PKC consensus
sites had no effect on the transient
nature of EGFP-PKCII transloca-
tion in response to agonist treat-
ment (Fig. 4). However, the muta-
tion of any one of the PKC
phosphorylation consensus sites in
AT1AR, either individually or in
combination, significantly increased
the number of cells exhibiting either
persistent or repetitive EGFP-PKCI
translocation responses (Fig. 4).
Therefore, we examined whether
agonist-stimulated DAG responses
were also altered by AT1AR-S331/
338/348A-expressing cells using the
YFP-PKCC1domainDAG reporter
construct. We found that the activa-
tion of the AT1AR-S331/338/348A
resulted in persistentDAG formation
in98%of cells (Fig. 5).Thus, similar to
the overexpression of PKCI, the
mutation of PKCconsensus sites in theAT1ARC-tail also resulted
in alterations in coupling of the AT1AR to DAG formation.
Role of PLDs in AT1AR-stimulated Persistent DAGFormation
and PKC Translocation—Not only was the AT1AR reported to
bind directly to PLD and regulate the activity of the enzyme
(22), but PLD activation via the metabolism of phosphatidic
acid provides an alternative cellular mechanism for the forma-
tion ofDAG (23). Therefore, we testedwhether persistentDAG
formation and PKCI translocation was PLD-mediated by co-
transfecting cells with siRNAs for PLD1 and PLD2 that were
previously reported to effectively knock down PLD protein
FIGURE 2. PKCI translocation response to AT1AR activation. HEK 293 cells were transfected with cDNA
plasmids encoding EGFP-PKCI (2 g) and HA-AT1AR (10 g) and treated with 100 nM Ang II. Shown are
representative EGFP-PKCI response patterns. These responses include transient EGFP-PKCI translocation
(41/47 cells) (A), persistent EGFP-PKCI translocation (4/47 cells) (B), and oscillatory EGFP-PKCI translocation
following agonist washout (2/47 cells) (C ). The data are plotted below as the relative change in EGFP fluores-
cence intensity in the circular (white) region of interestwithmaximal cytosolic fluorescence normalized to zero
and minimum cytoplasmic fluorescence normalized to one. The data are collected from six independent
experiments. Thewhite bars represent 10 m. The black bar represents the duration of agonist treatment.
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expression. In cells transfected with scrambled siRNA AT1AR-
S331/338/348A activation resulted in the persistent plasma
membrane localization of the YFP-PKC C1 domain DAG
reporter construct in all cells tested (Fig. 6A). In contrast, in
cells transfected with PLD1 and PLD2 siRNAs DAG responses
became predominantly transient (76% of cells) (Fig. 6A), indi-
cating that PLD activation was involved in persistent DAG for-
mation following AT1AR-S331/338/348A activation. Treat-
ment of cells with both PLD1 and PLD2 siRNAswas required to
prevent persistent DAG formation (data not shown). However,
in cells treated with PLD1/2 siRNA persistent PKCI trans-
location responses to AT1AR-S331/338/348A-stimulated
responses were unaltered when compared with cells trans-
fected with control siRNA (Fig. 6B). In contrast, in cells
expressing AT1AR-S331/338/348A and treated with PLD1/2
siRNA the plasma membrane translocation of EGFP-PKC, a
novel PKC isozyme that lacks the calcium binding C2 domain,
became predominantly transient rather than persistent (Fig.
6C). PKCII translocation was not affected by the PLD1 and
PLD2 siRNAs (data not shown). Interestingly, the initiation of
persistent DAG formation, as well as persistent PKCI and
PKC translocation responses, was dependent upon the activa-
tion of PLC as the pretreatment of cells with the PLC inhibitor
U73122 prevented the plasma membrane translocation of the
YFP-PKC C1 domain, EGFP-PKCI, and EGFP-PKC
(Fig. 6D).
Role of Calcium in AT1AR-stimulated PKCI and PKCII
Membrane Translocation—Because persistent PKCI trans-
location responses were not attenuated by PLD siRNA treat-
ment, we investigated the role of both intracellular and
extracellular calcium pools in regulating the plasma mem-
brane translocation of GFP-PKCI and GFP-PKCII. To
examine the role of intracellular calcium stores, cells were
pretreated for 30 min with either 50 M calcium chelator
BAPTA-AM or 1 M thapsigargin to deplete intracellular
calcium stores prior to agonist stimulation of the AT1AR-
S331/338/348A mutant. Treatment of cells with either
BAPTA-AM or thapsigargin prevented AngII-stimulated
translocation of both EGFP-PKCI and EGFP-PKCII in all
FIGURE 3. AT1AR-stimulated DAG formation in PKCI- and PKCII-ex-
pressing cells.HEK 293 cells were transfectedwith cDNAplasmids encoding
HA-PKCI (2 g) or HA-PKCII (2 g) along with YFP-PKC C1 domain (1 g)
andHA-AT1AR (10g) and treatedwith 100 nMAng II. Changes in intracellular
DAG concentrations were assessed by the cytosol to plasma membrane
translocation of a YFP-PKC C1 domain reporter construct. Cells were scored
as either exhibiting transient or persistent YFP-PKCC1domain translocation
responses. The numbers in parentheses represent the total number of cells
counted from six different experiments. Error bars indicate 2 S.D. (95% confi-
dence intervals). *, p  0.05 compared with cells expressing PKC C1 and
AT1AR.
FIGURE 4. PKC translocation responses in cells expressing AT1AR PKC
consensus sitemutants.HEK293 cellswere transfectedwith cDNAplasmids
encoding EGFP-PKCI (2g) or EGFP-PKCII (2g) along with 10g of plas-
mid cDNA encoding either HA-AT1AR, HA-AT1AR-S331A, HA-AT1AR-S338A,
HA-AT1AR-S348A, or HA-AT1AR-S331/338/348A and treated with 100 nM Ang
II. Cells were scored as exhibiting either transient, persistent, or repetitive
EGFP-PKC translocation responses. The numbers in parentheses represent
the total number of cells counted from six different experiments. Error bars
indicate 2 S.D. (95% confidence intervals). *, p  0.05 compared with the
percentage of cells in which PKCI showed the same type of response when
co-expressed with wild type AT1AR.
FIGURE 5. Wild type and mutant AT1AR-stimulated DAG formation. HEK
293 cells were transfected with cDNA plasmids encoding YFP-PKC C1
domain (1g) along with 10g of plasmid cDNA encoding either HA-AT1AR,
HA-AT1AR-S331/338/348A, or HA-AT1AR-S331/338/348A cotransfected with
HA-PKCI (2g) and treatedwith 100 nMAng II. Changes in intracellular DAG
concentrationswere assessed by the cytosol to plasmamembrane transloca-
tion of the YFP-PKC C1 domain reporter construct. Cells were scored as
either exhibiting transient or persistent YFP-PKC C1 domain translocation
responses. The numbers in parentheses represent the total number of cells
counted from six different experiments. Error bars indicate 2 S.D. (95% confi-
dence intervals). *, p  0.05 compared with cells expressing PKC C1 and
AT1AR.
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cells tested (data not shown). In contrast, preincubation of
cells with 2.5 mM EDTA did not prevent the transient trans-
location of either GFP-PKCI or GFP-PKCII in response to
AT1AR-S331/338/348A activation (Fig. 7). However, persis-
tent PKCI translocation responses were not observed in
AT1AR-S331/338/348A-activated cells treated with EDTA.
Taken together, these data suggested that the release of cal-
cium from intracellular stores was essential for the initiation
of PKCI and PKCII translocation responses and that the
influx of extracellular calcium must also be required for the
persistent localization of PKCI to the plasma membrane.
To further evaluate the role of extracellular calcium in the
activation of PKCI by AT1AR, we tested the effect of perfusing
cells with 2.5 mM EGTA subsequent to the induction of a per-
sistent EGFP-PKCI membrane translocation response. Ago-
nist activation of the AT1AR-S331/338/348A mutant resulted
in persistent EGFP-PKCI plasma membrane translocation in
23/47 cells tested, and when the bath medium was switched by
perfusion to include EGTA, EGFP-PKCI translocation was
terminated in all 23 cells (Fig. 8). However, when both Ang II
and EGTA were washed out by perfusion, PKCI translocated
back to the plasma membrane in
21/23 cells. These results suggested
that persistent PKCI membrane
localization was also dependent
upon the recruitment of an extracel-
lular calcium influx that remained
engaged in the absence of agonist
stimulation.
Electrophysiological Character-
ization of the Extracellular Calcium
Current—To determine whether
the AT1AR-mediated increase in
extracellular calcium entry could be
resolved via electrophysiology, we
carried out whole cell patch clamp
recordings from HEK 293 cells
transfected with either wild type
AT1AR or AT1AR-S331/338/348A
along with either PKCI or PKCII.
Cells were held at a potential of20
mV before application of a voltage
ramp from 60 to 40 mV. In the
absence of Ang II treatment, only
negligible current activity could be
observed (Fig. 9,A and B, 0s). Appli-
cation of 100 nMAngII to a subset of
cells expressing mutant AT1AR-
S331/338/348A along with EGFP-
PKCI resulted in the appearance of
substantial current activity that
reversed at about15 mV (Fig. 8A,
600s), which is consistent with a
non-selective cation channel. In
contrast, Ang II tended to evoke
much smaller currents in cells
expressing AT1AR-S331/338/348A
and EGFP-PKCII (Fig. 9B, 600s).
Fig. 9C summarizes the effects of Ang II treatment across a total
of 91 cells examined. In cells expressing EGFP-PKCI,70% of
the cells failed to respond to Ang II application with a signifi-
cant (i.e. 0.05 nS conductance) inward current, whereas the
remaining 30% responded with an average whole cell conduct-
ance of2 nS, consistent with what we observed for persistent
PKCI translocation responses. When recording from cells
expressing the AT1AR-S331/338/348A mutant, the fraction of
responding cells increased to55%, with an average conduct-
ance of responding cells of just greater than 2 nS. Treatment of
the cells with 1 M PKC inhibitor chelerythrine reduced the
inward current in responding cells that expressed the AT1AR-
S331/338/348A mutant and PKCI (Fig. 9C). Hence, cells
expressing PKCII tended to show only a small degree of cur-
rent activity, whereas cells expressing PKCI were able to sup-
port larger inward currents. Moreover, in the PKCI-express-
ing cells, theAT1AR-S331/338/348Amutantwasmore effective
in triggering current activity thanwild typeAT1AR, and thiswas
dependent upon PKCI activity. These results were consistent
with the observation that persistent PKCI translocation
FIGURE 6. Effect of PLD1/2 siRNA on persistent DAG formation as well as persistent PKCI and PKC
translocation responses in cells expressing AT1AR-S331/338/348A. HEK 293 cells were transfected with
cDNA plasmids encoding HA-AT1AR-S331/338/348A (1 g) and either the YFP-PKC C1 domain reporter con-
struct (A), EGFP-PKCI (B), or EGFP-PKC (C ) along with either scrambled (100 pM) or both PLD1 (100 pM) and
PLD2 (100pM) siRNAduplex and stimulatedwith 100nMAngII.D, HEK293 cells transfectedwith cDNAplasmids
encoding HA-AT1AR-S331/338/348A along with either the YFP-PKC C1 domain reporter construct, EGFP-
PKCI, or EGFP-PKCwere pretreated with 10M U73122 for 15min prior to receptor stimulation with 100 nM
AngII. Shown are the percentage of HEK 293 cells that exhibited either transient, persistent, repetitive, or no
translocation responses for each of the fluorescent reporter constructs. The numbers in parentheses represent
the total number of cells counted from six different experiments. Error bars indicate 2 S.D. (95% confidence
intervals).
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responses were more reliably observed in AT1AR-S331/338/
348A mutant-expressing cells.
Fig. 10, A and B, displays the time courses for the Ang II-
stimulated effects on whole cell conductance for the wild type
(Fig. 10A) and S331/338/348A mutant (Fig. 10B) AT1AR for
cells exhibiting current increases. For both wild type and S331/
338/348A mutant AT1AR, the effects of Ang II occur with an
approximate 3-min delay after agonist application. Moreover,
in particular for cells expressing the AT1AR-S331/338/348A
mutant, a separation in current responses between cells
expressing PKCI and PKCII is clearly evident (Fig. 10B),
again consistent with the observed translocation responses for
EGFP-PKCI and EGFP-PKCII (Fig. 4).
DISCUSSION
In the present studywe have shown that the alternative splice
variants for PKC, PKCI and PKCII, exhibit distinct pat-
terns of membrane translocation in response to AT1AR activa-
tion. We find that, whereas PKCII transiently translocates to
the plasma membrane in response
to AT1AR agonist activation, PKCI
displays two additional response
patterns: 1) persistent plasma mem-
brane translocation and 2) repetitive
localization between the cytosol and
plasma membrane following the
removal of agonist. The observed dif-
ference in AT1AR-stimulated PKCI
and PKCII responses appears to be
regulated,atleastinpart,byPKCphos-
phorylation at three consensus sites
localized to the AT1AR carboxyl-ter-
minal tail. Mutation of any individual
PKC consensus site: 1) increases the
probability that PKCI will persis-
tently translocate to theplasmamem-
brane, 2) results in sustained DAG
responses, 3) leads to the recruitment
of an extracellular calcium current and 4) does not alter PKCII
responses. Taken together, these results suggest that PKC-medi-
ated phosphorylation may play an important role in regulating
AT1AR coupling to persistent DAG formation and the recruit-
ment of an extracellular calcium current.
Angiotensin II-stimulated calcium and DAG signaling are
typically characterized by both biphasic and sustained
responses (1). Therefore, we propose the following model for
the mechanism underlying the observed switch from transient
to sustained calciumandDAGresponses followingAT1AR acti-
vation (Fig. 11). First, stimulation of the AT1AR results in tran-
sient increases in intracellular calcium, DAG, and inositol 1,4,5
trisphosphate levels, resulting in the release of intracellular cal-
cium stores and the transient activation of both PKCI and
PKCII. Second, the release of calcium from intracellular stores
is essential for the initiation of all alternative PKC translocation
responses. Third, we propose that under some conditions the
AT1AR escapes phosphorylation at each of three PKCphospho-
rylation consensus sites (see following sections for discussion),
resulting in sustained PLD-mediated DAG formation via the
metabolism of phosphatidic acid. Fourth, AT1AR coupling to
PLD-mediated DAG formation is also increased by the expres-
sion of PKCI, but not PKCII, suggesting that PKC isoform-
specific receptor phosphorylation may be involved in regulat-
ing this process. One possible explanation for this observation
may be that PKCII, but not PKCI, recognizes the AT1AR as a
substrate. Fifth, we also observed that in PKCI-expressing
cells the AT1AR exhibits the capacity to recruit an extracellular
calcium current and the probability that this will occur is sig-
nificantly enhanced by the mutation of PKC consensus sites in
the AT1AR C-tail. Sixth, although both calcium and DAG are
known to contribute to the membrane localization of conven-
tional PKC isozymes, the PLD-mediated source of DAG is not
required for the sustained localization of PKCI at the mem-
brane.However, it is essential for the persistent translocation of
the novel PKC isoform. Finally, the sustained localization of
PKCI at the plasma membrane is absolutely dependent upon
AT1AR-stimulated influx of extracellular calcium and PKCI
activity, as the establishment of this current is only observed in
FIGURE 7. Independence of transient PKC translocation on extracellular calcium. HEK 293 cells were
transfectedwith cDNAplasmids encodingHA-AT1AR-S331/338/348A (10g) and either EGFP-PKCII (2g) (A)
or EGFP-PKCI (2g) (B) andwere pretreated with 2.5mM EGTA prior to being exposed to 100 nM Ang II in the
presenceof 2.5mMEGTA.Blackbars shows thedurationof EGTA treatment.Arrows indicate the timesof agonist
infusion and washout. The data are plotted as the relative change in GFP fluorescence intensity with maximal
cytosolic fluorescencenormalized to zero andminimumcytoplasmic fluorescencenormalized toone. Thedata
are representative of six independent experiments.
FIGURE 8. Role of extracellular calcium in persistent PKCI translocation
responses. HEK 293 cells were transfected with cDNA plasmids encoding
HA-AT1AR-S331/338/348A (10 g) and EGFP-PKCI (2 g) and were treated
with 100 nM Ang II prior to being exposed to 2.5 mM EGTA in the presence of
100 nM Ang II. Arrows indicate the times at which cells were treated with
agonist, treated with agonist in the presence of 2.5 mM EGTA, and washed
with agonist- and EGTA-free medium. The data are plotted as the relative
change in EGFP fluorescence intensity with maximal cytosolic fluorescence
normalized to zero and minimum cytoplasmic fluorescence normalized to
one. The data are representative of 21/23 cells showing persistent transloca-
tion responses from six independent experiments.
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PKCI-expressing cells and can be prevented by a PKC inhibi-
tor. This suggests that PKCI, but not PKCII, activity is
required for the recruitment of the current. The repetitive
translocation of PKCI in some cells may involve repetitive
activation of PLC similar to what we have previously reported
for mGluR1 (17). Overall, PKC isoform-specific activity con-
tributes to the regulation of AT1AR-stimulated patterns of sec-
ond messenger activation.
There are a number of potentialmechanisms bywhich PKC
splice variants may respond differently to alterations in second
messenger levels. One potential explanation for PKC subtype-
specific response patterns is related to the differential sensitiv-
FIGURE 9.Whole cell patch clamp recordings fromHEK 293 cells.HEK 293 cells were transfected with cDNA plasmids encoding either HA-AT1AR (10g) or
HA-AT1AR-S331/338/348A (10 g) along with either GFP-PKCI (2 g) or GFP-PKCI (2 g). Shown are representative current traces reflecting whole cell
current activity in tsA-201 cells expressing the HA-AT1AR-S331/338/348A with either PKCI (A) or PKCII (B) before and after stimulation with 100 nM Ang II.
Currents were elicited by application of a voltage ramp (between60 mV and40 mV) from a holding potential of20 mV. C, shown is a summary of Ang
II-mediated whole cell current activity. Currents were elicited as outlined under “Experimental Procedures”, and whole cell conductance values were deter-
mined by liner fits to the inward current data between60 and30mV. In each case, conductance values obtained in the absence of Ang II were subtracted
from those observed after Ang II application. Hollow symbols reflect Ang II-mediated conductances0.05 nS (i.e. responding cells); filled symbols reflect cells
where Ang II-mediated effects smaller than 0.05 nS. The bars reflect mean conductance values obtained from only the responding cells. The black portions of
the pie charts indicate the percentage of cells that responded to Ang II application. Error bars denote S.E.
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ity of PKCI and PKCII to increases in intracellular calcium
and DAG levels. Keranen and Newton (24) have demonstrated
that the PKCI and PKCII V5 domains regulate differences in
the calcium-dependent affinity of the enzymes for acidic mem-
branes. Consistent with this observation, we showed that
PKCI and PKCII exhibit distinct translocation patterns in
response to mGluR1a activation, even when expressed in the
same cell (17). PKCII activation appears to be primarily regu-
lated by alterations in intracellular calcium released from intra-
cellular stores and is relatively insensitive to changes to elevated
DAG, whereas PKCI activity is sensitive to both calcium and
DAG. We previously identified two residues in the PKCII V5
domain that suppress PKCI-like responses for PKCII.
The initiation of both transient and persistent PKCI
responses by AT1AR requires the release of calcium from intra-
cellular stores. However, only the persistent responses required
the influx of extracellular calcium. This influx of extracellular
calcium is unlikely to involve AT1AR coupling to calcium-spe-
cific voltage-activated plasma membrane channels, because
HEK 293 cells do not express these channels (25). Rather the
dependence on extracellular calcium for the persistent PKCI
plasmamembrane translocation is likely due to the recruitment
of nonspecific cation channels, such as transient receptor
potential channels (TRPCs) (Fig. 11). Cayouette et al. (26) have
recently shown that activation of muscarinic receptors in HEK
293 cells or depletion of intracellular calcium increases the lev-
els of TRPC6 at the plasma membrane. Similarly, other groups
have shown that TRPC can be activated by stimulation of Gq-
coupled receptors (27, 28). Therefore, one potential mecha-
nism by which the calcium-dependent persistent membrane
localization of PKCI can be mediated is through activation of
AT1AR-stimulated membrane targeting and activation of
TRPCs. The activation of the TRPC current by the AT1AR
appears to be dependent upon PKCI activity. However, the
relevance and/or identity of the specific TRPC mediating the
influx of extracellular calcium in our model remain to be
determined.
Unlike PKCII, PKCI exhibits the capacity to be persis-
tently localized at the plasma membrane in response to AT1AR
activation; this response persists even after the cells are per-
fusedwith agonist-freemedium. This differs fromwhat we pre-
viously observed formGluR1a, where the perfusion of cells with
agonist-free medium led to the cessation of PKCI activation
and localization at the plasma membrane (17). Moreover,
PKCI localization at the plasma membrane in mGluR1a-ex-
pressing cells was solely dependent upon persistent changes in
DAG formation without concomitant alterations in intracellu-
lar calcium concentrations. This suggests that in response to
AT1AR, but not mGluR1a activation, there is a PKC splice
variant-specific alteration in HEK 293 calcium homeostasis
that becomes independent of receptor activation. Of particular
interest is the possibility that PKCI contributes directly to the
AT1AR-dependent recruitment of a TRPC-mediated influx of
extracellular calcium. Several studies have suggested that
TRPC activity is activated by increases in intracellular DAG
levels (27, 28). However, in our study, AT1AR coupling to extra-
FIGURE 10. Time course of Ang II-stimulated currents in HEK 293 cells. A,
time course for AngII-stimulated currents in HEK 293 cells expressing
HA-AT1AR with and without EGFP-PKCI and EGFP-PKCII. B, time course for
AngII-stimulated currents in tsA-201 cells expressing HA-AT1AR-S331/338/
348A with and without EGFP-PKCI and EGFP-PKCII. Only cells with Ang
II-induced effects on whole cell conductance 0.05 nS are included in the
figure. Error bars denote S.E.
FIGURE 11. Schematic representation of the proposed model for AT1AR-
stimulated PKC isoform-specific translocation responses. A detailed
description of the figure can be found under “Discussion.” Ca2, calcium; ER,
endoplasmic reticulm; IP3, inositol 1,4,5 trisphosphate; IP3R, IP3 receptor; PKC,
protein kinase C; PLC, phospholipase C; PLD, phospholipase D; TRPC, tran-
sient receptor potential channel.
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cellular calcium is only observed in PKCI-expressing cells,
whereas sustained levels of DAG signaling are observed in both
PKCI- and PKCII-expressing cells. An alternative mecha-
nism by which TRPC activity is recruited is through the recep-
tor-regulated exocytotic insertion of an intracellular vesicular
pool of TRP channels into the plasmamembrane (26). Interest-
ingly, we often observe the translocation of PKCI, but not
PKCII, to intracellular vesicles in response to AT1AR activa-
tion (data not shown). Thus, it is possible that PKCI activation
may directly modulate TRPC exocytosis. However, extensive
additional experimentation will be required to test this
hypothesis.
We observed that the mutation of any individual PKC phos-
phorylation consensus site in the AT1AR carboxyl-terminal tail
results in the persistent activation of DAG formation and
increases the probability that PKCI will persistently localize to
the plasmamembrane in response to AT1AR activation. In con-
trast, PKCII response patterns remain unchanged in cells
expressing the AT1AR-S314/338/348A mutant. This observa-
tion suggests that feedback phosphorylation and heterologous
AT1AR desensitization by PKCI and PKCII may play an
important role in regulating PKCI membrane translocation
patterns. The probability that PKCI will exhibit persistent
plasmamembrane localization is increased following themuta-
tion of any of the three PKC consensus sites localized to the
AT1AR carboxyl-terminal tail. This suggests that phosphoryla-
tion at all three sitesmay be required to attenuate PKCI trans-
location. However, the alterations in DAG signaling by PKC
phosphorylation site AT1AR mutants does not appear to
require the overexpression of PKCI, because persistent acti-
vation of DAG signaling is observed in 98% of cells expressing
the AT1AR-S314/338/348A mutant alone. Thus, endogenously
expressed PKC isozymes are likely sufficient to mediate heter-
ologous AT1AR desensitization and prevent AT1AR coupling to
a PLC-independent source of DAG.
In summary, we have uncovered an intricate and compli-
catedmechanism bywhich the activity of PKCI and PKCII is
differentially regulated in response to AT1AR activation. It
appears that persistent membrane translocation of PKCI is
dependent upon both the release of calcium from intracellular
stores and the recruitment of an extracellular calcium source.
We hypothesize that this source of calcium might involve the
PKCI-specific recruitment of a TRP channel. Overall, we find
that the patterning of AT1AR second messenger response pat-
terns is regulated by PKC isoform-specific sensitivity to alter-
ations in intracellular calcium and DAG levels, heterologous
desensitization, and PKC isoform substrate specificity.
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